KM Research Hub
← 返回论文库
待处理 入排:待复核 图源:待检查 入排置信度 0.45

Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer.

Takayuki Tsuji, Satoru Matsuda, Masashi Takeuchi, Hirofumi Kawakubo, Yuko Kitagawa

Jpn J Clin Oncol 53(8) 645-652

PMID37282626
PMCID-
DOI10.1093/jjco/hyad051
发表日期2023-06-07
入排依据:The record is a review article summarizing multiple trials, not an original result report of a single randomized trial. It lacks primary time-to-event efficacy data (e.g., KM curves, HR) for any specific trial, which is required for eligibility.
摘要

摘要

Esophageal cancer has one of the poorest prognoses among all cancer types, due to the propensity for an early spread through the lymphatics and the difficulty to perform surgical treatment. To improve the prognosis, the management of esophageal cancer has been developed through the conduct of several clinical trials worldwide. In western societies, neoadjuvant chemoradiotherapy has been established as the standard treatment approach, as indicated by the results of the CROSS trial. Recently, the Japanese JCOG1109 trial demonstrated the significant improvement of survival by neoadjuvant triplet chemotherapy. As an adjuvant treatment, an immune checkpoint inhibitor has shown promising results in the CheckMate-577 trial. Including adjuvant S-1 mono therapy as another option, a randomised control phase III study will determine the ideal treatment for surgically resectable esophageal cancer. Furthermore, the efficacy and safety of neoadjuvant cisplatin +5-fluorouracil or DCF plus nivolumab are examined in the JCOG1804E (FRONTiER) study. In addition to definitive chemoradiation therapy, the SANO trial is examining the safety and efficacy of active surveillance after neoadjuvant chemoradiotherapy, which might give us the choice to adopt organ preservation approach. The development of treatment has progressed dramatically with the advent of immunotherapy. Considering the biomarkers to predict the treatment response and prognosis, individualised multidisciplinary treatment strategies should be established for esophageal cancer patients.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。